Bionime Corp
TWSE:4737

Watchlist Manager
Bionime Corp Logo
Bionime Corp
TWSE:4737
Watchlist
Price: 54.5 TWD 1.49% Market Closed
Market Cap: NT$3.7B

Operating Margin

-6.8%
Current
Declining
by 4.7%
vs 3-y average of -2.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6.8%
=
Operating Income
NT$-131m
/
Revenue
NT$1.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6.8%
=
Operating Income
NT$-131m
/
Revenue
NT$1.9B

Peer Comparison

Country Company Market Cap Operating
Margin
TW
Bionime Corp
TWSE:4737
4B TWD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.8B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.1B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.7B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.6B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.4B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.5B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.6B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.8B USD
Loading...

Market Distribution

Lower than 84% of companies in Taiwan
Percentile
16th
Based on 1 045 companies
16th percentile
-6.8%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

Bionime Corp
Glance View

Market Cap
3.7B TWD
Industry
Health Care

Bionime Corp. engages in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company is headquartered in Taichung, Taichung. The company went IPO on 2009-08-26. The firm's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The firm distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.

Intrinsic Value
36.65 TWD
Overvaluation 33%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-6.8%
=
Operating Income
NT$-131m
/
Revenue
NT$1.9B
What is Bionime Corp's current Operating Margin?

The current Operating Margin for Bionime Corp is -6.8%, which is below its 3-year median of -2.1%.

How has Operating Margin changed over time?

Over the last 3 years, Bionime Corp’s Operating Margin has decreased from 5.5% to -6.8%. During this period, it reached a low of -8.4% on Mar 31, 2025 and a high of 5.9% on Dec 31, 2022.

Back to Top